Sort
89,613 grants matching “depression”
Cannabinoid CB1 and CB2 receptors and drug abuse
$968,160Zheng-Xiong Xi · National Institute On Drug Abuse · ZIG · FY2022 · DA
2-Generation Interventions to Improve Cardiovascular Health in Indiana and Illinois Through Home Visiting (2-NOURISH)
$968,130Shiv Darius Tandon · Northwestern University At Chicago · UH3 · FY2024 · HL
Mobile Health to Monitor Risk for COVID-19 and Improve Mental Health during the Pandemic
$968,064Michael J Zvolensky · University Of Houston · R01 · FY2022 · MH
Novel PDE Inhibitors for Treatment of Cognitive Dysfunction in Schizophrenia
$968,007Lawrence Paul Wennogle · Intra-Cellular Therapies, Inc. · R44 · FY2008 · MH
Understanding the Connections among Genes, Environment, Family Processes, and Mental Health
$967,922William G. Axinn · University Of Michigan At Ann Arbor · R01 · FY2020 · MH
Noninvasive modulation of deep brain circuits for treatment-resistant depression
$967,781Brian James Mickey · University Of Utah · R61 · FY2024 · MH
Population-Based Epidemiologic Research
$967,587Kathleen R Merikangas · National Institute Of Mental Health · ZIA · FY2020 · MH
Motor Activity Research Consortium for Health (mMarch)
$967,587Kathleen R Merikangas · National Institute Of Mental Health · ZIA · FY2020 · MH
BEHAVIORAL INTERVENTIONS FOR WOMEN WITH HIV/AIDS - NY
$967,187Clinical Directors Network, Inc. · R01 · FY2003 · MH
A Digital Health Technology to Prevent Family Violence and Improve Child Mental Health
$967,170Lisa Ann Reiter · Northwest Prevention Science Inc · R42 · FY2025 · MH
Delivering Written Exposure Therapy for PTSD in Underserved Primary Care Settings
$967,012Lisa Seidel Meredith · Rand Corporation · R01 · FY2025 · MH
Transcending COVID-19 barriers to pain care in rural America: Pragmatic comparative effectiveness trial of evidence-based, on-demand, digital behavioral treatments for chronic pain
$966,674Brennan Spiegel · Cedars-Sinai Medical Center · R01 · FY2022 · NR
Understanding and Preventing Childhood Drug Use Risk
$966,615Thomas J Dishion · University Of Oregon · R01 · FY2010 · DA
Outcomes in Rheumatic Diseases
$966,532Michael Ward · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2011 · AR
A feasibility trial of esketamine plus cognitive behavioral therapy for patients with major depressive disorder who are hospitalized for suicidal ideation
$966,043Samuel Wilkinson · Yale University · R01 · FY2023 · MH
2/3: Pedigree-Based Whole Genome Sequencing of Affective and Psychotic Disorders
$965,889John Blangero · University Of Texas Rio Grande Valley · U01 · FY2018 · MH
Functional Bowel Disorders in Chinese Medicine
$965,542Brian M Berman · University Of Maryland Baltimore · U19 · FY2007 · AT
A RANDOMIZED CONTROLLED TRIAL OF PCIT-ED FOR PRESCHOOL DEPRESSION
$965,460Joan L Luby · Washington University · R01 · FY2016 · MH
Enhanced supercooling for extending non-freezing preservation in preclinical porcine and human donor livers
$965,379Michael John Taylor · Sylvatica Biotech, Inc. · R44 · FY2024 · DK
Metabolic Effects of Newer Antipsychotics in Older Pts
$965,253Dilip V Jeste · Veterans Medical Research Fdn/San Diego · R01 · FY2007 · MH
Clinical and Translational Core
$964,949Bradley J Willcox · Kuakini Medical Center · P20 · FY2019 · GM
Longitudinal Natural History of Disorders Associated with Hyperphenylalaninemia
$964,754Georgianne L Arnold · Oregon Health & Science University · U54 · FY2022 · HD
Longitudinal Natural History of Disorders Associated with Hyperphenylalaninemia
$964,754Georgianne L Arnold · Oregon Health & Science University · U54 · FY2021 · HD
Prospective studies on Parkinson's disease
$964,668Honglei Chen · National Institute Of Environmental Health Sciences · ZIA · FY2012 · ES
Novel PDE Inhibitors for Treatment of Cognitive Dysfunction in Schizophrenia
$964,601Lawrence Paul Wennogle · Intra-Cellular Therapies, Inc. · R44 · FY2010 · MH